63 rue de l'Est
92100 Boulogne-Billancourt - FRANCE Site web

Key figures

Creation date: 2002
Number of employees: 18
Investment date: 08/07/2020
Fund name: Mérieux Participations 3

Company presentation

Laboratoires CTRS (Cell Therapies Research & Services), is a French pharmaceutical company focused on developing and marketing drugs for rare diseases and with a strong and growing international presence. Its main areas of expertise are Hereditary metabolic diseases and Oncology-haematology-immunology.

CTRS has developed a smart and efficient business model thanks to its ability to secure strategic partnerships (strong and long-lasting relationship with AP-HP) combined with the ability to detect unmet needs (network of KOLs, management and doctors) and a smart regulatory strategy.